WallStSmart

Citigroup Inc. (C)vsOaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

C leads profitability with a 20.4% profit margin vs 0.0%. C trades at a lower P/E of 15.8x. C earns a higher WallStSmart Score of 82/100 (A-).

C

Exceptional Buy

82

out of 100

Grade: A-

Growth: 8.7Profit: 6.5Value: 7.0Quality: 5.0

OACC

Avoid

30

out of 100

Grade: F

Growth: 4.3Profit: 3.5Value: 4.7Quality: 5.8
Piotroski: 2/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

C6 strengths · Avg: 9.5/10
Market CapQuality
$223.88B10/10

Mega-cap, among the largest globally

Price/BookValuation
1.1x10/10

Reasonable price relative to book value

Operating MarginProfitability
34.1%10/10

Strong operational efficiency at 34.1%

EPS GrowthGrowth
56.1%10/10

Earnings expanding 56.1% YoY

Profit MarginProfitability
20.4%9/10

Keeps 20 of every $100 in revenue as profit

PEG RatioValuation
0.718/10

Growing faster than its price suggests

OACC1 strengths · Avg: 10.0/10
Debt/EquityHealth
0.0010/10

Conservative balance sheet, low leverage

Areas to Watch

C1 concerns · Avg: 3.0/10
Return on EquityProfitability
7.7%3/10

ROE of 7.7% — below average capital efficiency

OACC4 concerns · Avg: 3.8/10
P/E RatioValuation
35.6x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$262.54M3/10

Smaller company, higher risk/reward

Comparative Analysis Report

WallStSmart Research

Bull Case : C

The strongest argument for C centers on Market Cap, Price/Book, Operating Margin. Profitability is solid with margins at 20.4% and operating margin at 34.1%. Revenue growth of 16.9% demonstrates continued momentum.

Bull Case : OACC

The strongest argument for OACC centers on Debt/Equity.

Bear Case : C

The primary concerns for C are Return on Equity.

Bear Case : OACC

The primary concerns for OACC are P/E Ratio, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

C profiles as a growth stock while OACC is a value play — different risk/reward profiles.

C is growing revenue faster at 16.9% — sustainability is the question.

C generates stronger free cash flow (2.0B), providing more financial flexibility.

Monitor BANKS - DIVERSIFIED industry trends, competitive dynamics, and regulatory changes.

Bottom Line

C scores higher overall (82/100 vs 30/100), backed by strong 20.4% margins and 16.9% revenue growth. Both earn "Exceptional Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Citigroup Inc.

FINANCIAL SERVICES · BANKS - DIVERSIFIED · USA

Citigroup Inc. is an American multinational investment bank and financial services corporation headquartered in New York City. The company was formed by the merger of banking giant Citicorp and financial conglomerate Travelers Group in 1998; Travelers was subsequently spun off from the company in 2002. Citigroup owns Citicorp, the holding company for Citibank, as well as several international subsidiaries. Citigroup is incorporated in Delaware.

Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share

FINANCIAL SERVICES · SHELL COMPANIES · USA

Oaktree Acquisition Corp. III (OACC) is a special purpose acquisition company (SPAC) dedicated to merging with innovative firms in the life sciences sector. Led by a highly seasoned management team with deep expertise in healthcare investments, OACC seeks to capitalize on growth opportunities across diverse areas such as healthcare technology, therapeutics, and medical devices. The company prioritizes strategic partnerships and meticulous due diligence to maximize shareholder value, positioning itself for success in the dynamic and evolving landscape of life sciences.

Visit Website →

Want to dig deeper into these stocks?